Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy.

Sci Rep · 2022 · PMC8844048 · PMID 35165326

Europe PMC DOI

hedged sentence

0.0660

closest p · 1.3× alpha

0.0660

boldest claim

The sentences

showed a trendp = 0.066so close (0.05 < p ≤ 0.1)

At 6-month follow-up, patients with signs of metabolic syndrome showed a trend towards lower PHES compared to patients without these manifestations (− 6.3 ± 1.2 vs. − 3.6 ± 0.6; 95CI = − 0.2–5.6; p = 0.066).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.